Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Circulation

• Publication date

  1987-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.76.6.1251PMID 3677350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size.

  1984cited by this paper
• The effects of reperfusion of infarct-related coronary artery on serum creatine phosphokinase and left ventricular function.

  1984cited by this paper
• Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains.

  1984cited by this paper
• Effects of steroid treatment on release of cardiac myosin light chain II in acute myocardial infarction in dogs.

  1984cited by this paper
• A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

  1983cited by this paper
• Intracoronary thrombolysis in acute myocardial infarction: an attempt to quantitate its effect by comparison of enzymatic estimate of myocardial necrosis with left ventricular ejection fraction.

  1983cited by this paper
• Evaluation of methods for estimating infarct size by myosin LC2: comparison with cardiac enzymes.

  1983cited by this paper
• Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man.

  1983cited by this paper
• Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.

  1983cited by this paper
• Effects of Spontaneous and Streptokinase‐induced Recanalization on Left Ventricular Function After Myocardial Infarction

  1983cited by this paper
• Myocardial infarct size from serum cardiac myosin light chain. Clinical and experimental studies.

  1983cited by this paper
• Effects of nonsurgical myocardial reperfusion on plasma creatine kinase kinetics in man.

  1983cited by this paper
• Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.

  1983cited by this paper
• Enzymatic estimation of infarct size during reperfusion.

  1983cited by this paper
• Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion.

  1983cited by this paper
• Intracoronary thrombolysis in evolving myocardial infarction.

  1981cited by this paper
• Intracoronary thrombolysis in evolving myocardial infarction.

  1981cited by this paper
• Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris

  1981cited by this paper
• Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia.

  1981cited by this paper
• Assessment of myocardial infarct size by serial changes in serum cardiac myosin light chain II in dogs.

  1981cited by this paper
• Radioimmunoassay of cardiac myosin light chain II in the serum following experimental myocardial infarction.

  1979cited by this paper
• Radioimmunoassay of cardiac myosin light chain II in the serum following experimental myocardial infarction.

  1979cited by this paper
• Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase.

  1978cited by this paper
• Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.

  1976cited by this paper
• Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

  1975cited by this paper
• A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

  1975cited by this paper
• An Improved Basis for Enzymatic Estimation of Infarct Size

  1975cited by this paper
• The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

  1974cited by this paper
• Deleterious effects due to hemorrhage after myocardial reperfusion.

  1974cited by this paper
• Fractionation of the light chains from rat and rabbit cardiac myosin.

  1973cited by this paper
• Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.

  1971cited by this paper
• An improved procedure for serum creatine phosphokinase determination.

  1967cited by this paper
• Usefulness and limitations of radiographic methods for determining left ventricular volume.

  1966cited by this paper

• Is ischaemic heart failure an autoimmune disease?

  2023cites this paper
• An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression

  2021cites this paper
• Urinary Titin Is Increased in Patients After Cardiac Surgery

  2019cites this paper
• Promising Biomarkers in Acute Kawasaki Disease and Acute Coronary Ischemia

  2017cites this paper
• Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.

  2014cites this paper
• La apoptosis en el Infarto Agudo de Miocardio. Asociación de los polimorfismos Arg72Pro del gen P53 y T309G del gen MDM2 con el tamaño del infarto, la función ventricular izquierda post-infarto y el desarrollo de insuficiencia cardiaca

  2014cites this paper
• Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease ( JCS 2013 ) – Digest Version – JCS Joint Working Group Table of Contents

  2014cites this paper
• OUTCOME OF THROMBOLYTIC AND NONTHROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

  2012cites this paper
• Reduction of the cardiotoxicity of Doxorubicin: Demonstration by in vivo imaging with Bispecific antibody/radiolabeled negatively charged polymers

  2012cites this paper
• Biochemical markers of myocardial injury

  2007cites this paper
• Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.

  2005cites this paper
• Clinical significance of cardiac myosin light chain 1 in hemodialysis patients

  2005cites this paper
• Development of enzyme-linked immunosorbent assay for human cardiac myosin light chain I.

  2005cites this paper
• Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction

  2005cites this paper
• Clinical significance of heart fatty acid-binding protein in hemodialysis patients

  2004cites this paper
• Biochemical markers of myocyte injury in heart failure

  2004cites this paper
• Kawasaki disease.

  2004cites this paper
• Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan.

  2002cites this paper
• Cardiac marker responses to coronary artery bypass graft surgery with cardiopulmonary bypass and aortic cross-clamping.

  2002cites this paper
• Serum Concentration of Myosin Light Chain I and Left Ventricular Shortening Fraction in Neonates

  1999cites this paper
• Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty.

  1998cites this paper
• Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices.

  1998cites this paper
• Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.

  1998cites this paper
• Myosin light chain I grade: a simple marker for the severity and prognosis of patients with acute myocardial infarction.

  1998cites this paper
• Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome.

  1998cites this paper
• Myosin Light and Heavy Chains

  1998cites this paper
• Serum levels of cardiac troponin I and troponin T in estimating myocardial infarct size soon after reperfusion

  1997cites this paper
• Progress in myocardial damage detection: new biochemical markers for clinicians.

  1997cites this paper
• Time-dependent alterations of serum levels of triple-helix domain and 7S domain of type IV collagen in patients with acute myocardial infarction after successful reperfusion: limited relation to left ventricular ejection fraction.

  1997cites this paper
• Postoperative changes in myosin light chain and comparison with postoperative clinical variables in patients who have undergone valve surgery.

  1996cites this paper
• Pathophysiological analysis of serum troponin T release kinetics in evolving ischemic myocardial injury.

  1996cites this paper
• Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.

  1996cites this paper
• Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction.

  1996cites this paper
• Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter.

  1995cites this paper
• Serum myosin light chain determinations in patients with inflammatory myopathy--a preliminary report.

  1995cites this paper
• Calcium-binding proteins 1: EF-hands.

  1995cites this paper
• Myocardial infarct size by serum troponin T and myosin light chain 1 concentration.

  1995cites this paper
• Differences in Cardiac Myosin Light Chain-I Release Kinetics in Patients Undergoing Coronary Recanalization Therapy

  1995cites this paper
• Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients.

  1995cites this paper
• Serum cardiac troponin T in patients with acute myocardial infarction. Detection of coronary reperfusion and prediction of cardiac function.

  1995cites this paper
• Calcium-binding proteins. 1: EF-hands.

  1994cites this paper
• Inflammatory myopathy--early diagnosis and management by serum myosin light chains measurements.

  1994cites this paper
• Different time courses of cardiac contractile proteins after acute myocardial infarction.

  1994cites this paper
• Human ventricular myosin light chain isotype 1 as a marker of myocardial injury.

  1994cites this paper
• Concentration time courses of troponin and myosin subunits after acute myocardial infarction

  1994cites this paper
• Serum cardiac markers in hemodialysis patients

  1994cites this paper
• Atrial and Brain Natriuretic Peptides in Cardiovascular Diseases

  1994cites this paper
• Cardiac myosin light chain-1 release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar.

  1994cites this paper
• Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury.

  1994cites this paper
• Polymyositis associated with myocardial involvement: report of a case

  1993cites this paper
• Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty.

  1993cites this paper
• Myocardial Infarct Size Can Be Estimated From Serial Plasma Myoglobin Measurements Within 4 Hours of Reperfusion

  1993cites this paper
• Myosin light chain efflux after heart transplantation in infants and children and its correlation with ischemic preservation time.

  1993cites this paper
• Myocardial uptake of antimyosin antibody compared with serum myosin light chain I levels in patients with myocardial infarction

  1992cites this paper
• Circulating myosin light chain I levels after coronary reperfusion: A comparison with myocardial necrosis evaluated from single photon emission computed tomography with pyrophosphate

  1992cites this paper
• Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease

  1992cites this paper
• Development of an immunoradiometric assay kit for ventricular myosin light chain I with monoclonal antibodies.

  1992cites this paper
• Myosin, from the gene to the circulating forms.

  1990cites this paper
• Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging.

  1990cites this paper
• Assay of serum cardiac myosin heavy chain fragments in patients with acute myocardial infarction: determination of infarct size and long-term follow-up.

  1990cites this paper
• Intérêt du dosage de la myosine dans le diagnostic et le suivi de l'infarctus du myocarde

  1989cites this paper
• Quantification of Myocardial Infarct Size After Coronary Reperfusion by Serum Cardiac Myosin Light Chain II in Conscious Dogs

  1989cites this paper
• Infarct sizing after reperfusion by two-dimensional echocardiography and serum cardiac myosin light chain II in conscious dogs: dissociation between early left ventricular wall motion and ultimate infarct size.

  1989cites this paper
• Development of an immunoradiometric Assay Kit for Ventricular Myosln Light Chain I with Monoclonal Antibodies

  year unknowncites this paper